Table 1.
No.
of Expected Cases/No. of Observed
Cases |
||||
Invasive
Tumor |
Borderline Tumor |
|||
Cancer Type in Index Case | First-DegreeRelatives | Second-DegreeRelatives | First-DegreeRelatives | Second-DegreeRelatives |
Breast | 5/3.5 | 12/11 | 2/2.2 | 11/8.6 |
Ovary | 3*/.6 | 3/2.3 | 1/.4 | 4***/1.7 |
Pharynx | 0/.4 | 1/.6 | 0/.2 | 1/1 |
Esophagus | 1/.4 | 0/1.7 | 0/.2 | 0/1 |
Stomach | 1/.8 | 8/5 | 1/.4 | 4/3 |
Colon | 2/1.2 | 10***/6 | 0/.6 | 4/3.7 |
Rectum | 1/.8 | 0/4 | 1/.4 | 0/2.5 |
Liver | 0/.1 | 2***/.4 | 0/.05 | 0/.3 |
Pancreas | 2***/.4 | 1/2.3 | 1/.2 | 0/1.4 |
Larynx | 0/.2 | 2/.9 | 0/.1 | 3*/.6 |
Lung | 1/2.9 | 26*/16 | 1/1.4 | 5/8.9 |
Bone | 0/.09 | 0/.2 | 0/.06 | 0/.1 |
Connective tissue | 0/.15 | 0/.4 | 0/.09 | 0/.3 |
Melanoma | 0/.5 | 1/1.1 | 0/.3 | 0/.8 |
Cervix | 2/.8 | 3/2.1 | 1/.5 | 0/1.7 |
Uterus | 0/.4 | 1/2 | 0/.3 | 4***/1.4 |
Prostate | 2/.6 | 4/4 | 3**/.3 | 0/2 |
Testis | 0/.3 | 0/.4 | 0/.2 | 1/.3 |
Bladder | 1/.9 | 0/4 | 0/.4 | 1/2.4 |
Kidney | 0/.4 | 1/1.5 | 0/.2 | 0/1 |
Brain | 0/.6 | 3/1.7 | 0/.4 | 1/1.2 |
Thyroid | 1/.1 | 0/.3 | 0/.08 | 0/.2 |
Hodgkin | 0/.3 | 1/.6 | 2*/.2 | 0/.4 |
Non-Hodgkin lymphoma | 4**/.6 | 0/1.9 | 1/.4 | 0/1.2 |
Myeloma | 2*/.2 | 0/.9 | 0/.1 | 0/.5 |
Leukemia | 0/.6 | 0/1.7 | 0/.3 | 0/1.1 |
Other cancers | 0/.4 | 0/1.6 | 0/.2 | 0/1 |
Unknown | 0/.8 | 1/4 | 0/.4 | 0/2.5 |
All except nonmelanoma skin | 30*/19 | 80/82 | 14/11 | 39/51 |
All except skin, breast, and ovary | 22***/15 | 65/68 | 11/8 | 24/41 |
Note.—Number of male and female relatives at risk is 1,968.
P<.05.
P<.01.
P<.1.